Ambev S.A., through its subsidiaries, produces, distributes, and sells beer, draft beer, carbonated soft drinks (CSD), other non-alcoholic beverages, malt, and food products in the Americas. It operates through three segments: Brazil; Central America and the Caribbean; Latin America South; and Canada. The company offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Brahva Gold, Extra, Budweiser, Bud Light, Stella Artois, Corona, Modelo Especial, Beck, Leffe, Hoegaarden, Bucanero, Cristal, Mayabe, Cacique, Presidente, Brahma Light, President Light, Bohemia, The One, Banks, Deputy, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Pilsen, Ouro Fino, Patricia, Michelob Ultra, Busch, Labatt Blue, Alexander Keith's, and Kokanee brands. It also provides bottled water, isotonic beverages, energy drinks, coconut water, powdered and natural juices, and ready-to-drink teas under the Guaraná Antarctica, Natu, Gatorade, H2OH!, Lipton Iced Tea, Fusion, Do Bem, Pepsi, Canada Dry, Squirt, Red Rock, Pepsi-Cola, Seven Up, Nutrl, and Palm Bay and Mike's brands, as well as For Me wellness shots, a functional beverage. Ambev S.A. offers its products through a network of third-party distributors and a direct distribution system. The company was founded in 1885 and is headquartered in São Paulo, Brazil. Ambev S.A. is a subsidiary of Interbrew International B.V.
IPO Year: 2013
Exchange: NYSE
Website: ambev.com.br
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/4/2024 | $3.50 → $3.00 | Overweight → Equal Weight | Barclays |
| 3/1/2024 | Overweight → Neutral | JP Morgan | |
| 12/8/2023 | Underweight → Equal-Weight | Morgan Stanley | |
| 12/7/2023 | Buy | Citigroup | |
| 11/22/2023 | Hold | Jefferies | |
| 7/10/2023 | Neutral → Buy | BofA Securities | |
| 5/24/2023 | $3.74 | Outperform | Bernstein |
| 1/12/2023 | Sell → Buy | UBS | |
| 7/13/2022 | Neutral → Overweight | JP Morgan | |
| 11/3/2021 | Underperform → Neutral | B of A Securities |
Barclays downgraded AmBev from Overweight to Equal Weight and set a new price target of $3.00 from $3.50 previously
JP Morgan downgraded AmBev from Overweight to Neutral
Morgan Stanley upgraded AmBev from Underweight to Equal-Weight
Citigroup initiated coverage of AmBev with a rating of Buy
Jefferies initiated coverage of AmBev with a rating of Hold
BofA Securities upgraded AmBev from Neutral to Buy
Bernstein initiated coverage of AmBev with a rating of Outperform and set a new price target of $3.74
UBS upgraded AmBev from Sell to Buy
JP Morgan upgraded AmBev from Neutral to Overweight
B of A Securities upgraded Ambev from Underperform to Neutral
SÃO PAULO, March 11, 2024 /PRNewswire/ -- Ambev S.A. ([B3: ABEV3, NYSE:ABEV) announces that the Company's annual report on Form 20-F for the year ended December 31, 2023 was filed with the U.S. Securities and Exchange Commission - SEC ("SEC") on March 11, 2024 and is available on the Company's website (ri.ambev.com.br) and also on the SEC (www.sec.gov/edgar/). ADR holders may receive a hard copy of the Company's complete audited financial statements contained in the Form 20-F free of charge, upon request. To access the full document, please access the following links: click here. Ambev S.A. Investor Relations DepartmentContact e-mail: [email protected] View original content:https://www
SÃO PAULO, March 17, 2023 /PRNewswire/ -- Ambev S.A. ([B3: ABEV3, NYSE:ABEV) announces that the Company's annual report on Form 20-F for the year ended December 31, 2022 was filed with the U.S. Securities and Exchange Commission - SEC (www.sec.gov) on March 17, 2023 and is available on the Company's website (ri.ambev.com.br) and also on the Company's page on SEC's database (www.sec.gov/edgar/). ADR holders may receive a hard copy of the Company's complete audited financial statements contained in the Form 20-F free of charge, upon request. To access the full document, please access the following links: click here. CONTACT: Ambev S.A.Investor Relations DepartmentContact e-mail: [email protected]
SÃO PAULO, Brazil, March 18, 2022 (GLOBE NEWSWIRE) -- Ambev S.A. ([B3: ABEV3, NYSE:ABEV) announces that the Company's annual report on Form 20-F for the year ended December 31, 2021 was filed with the U.S. Securities and Exchange Commission - SEC (www.sec.gov) on March 18, 2022 and is available on the Company's website (ri.ambev.com.br) and also on the Company's page on SEC's database (www.sec.gov/edgar/). ADR holders may receive a hard copy of the Company's complete audited financial statements contained in the Form 20-F free of charge, upon request. To access the full document, please access the following link: click here Ambev S.A. Investor Relations Department Contact e-mail: ri@amb
NEW YORK, NY / ACCESSWIRE / May 6, 2021 / Ambev SA (FRA:AMNA) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 11:30 AM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/event/presentation/77479To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile.About Investor NetworkInvestor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what's trending. Dedicated to both the professional and the
SÃO PAULO, Brazil, March 19, 2021 (GLOBE NEWSWIRE) -- Ambev S.A. [B3: ABEV3; NYSE: ABEV] announces that the Company’s annual report on Form 20-F for the year ended December 31, 2020 was filed with the U.S. Securities and Exchange Commission - SEC (www.sec.gov) on March 19, 2021 and is available on the Company’s website (ri.ambev.com.br) and also on the Company’s page on SEC's database (www.sec.gov/edgar/). ADR holders may receive a hard copy of the Company’s complete audited financial statements contained in the Form 20-F, free of charge, upon request. To access the full document, please access the following links: click here or here. Ambev S.A.Investor Relations DepartmentContact e-mail
Barclays analyst Benjamin Theurer maintains Ambev (NYSE:ABEV) with a Equal-Weight and lowers the price target from $3 to $2.5.
Brazilian brewing company Ambev SA (NYSE:ABEV) reported first-quarter FY24 net revenue decline of 1.2% to R$20.3 billion. On an organic basis, net revenue gained 4.5%. Net revenue per hl slipped 1.4%. Consolidated volume was virtually flat (+0.1%), as positive performances in Brazil (+6.5% in NAB and +3.6% in Beer) and Central America and the Caribbean (CAC) (+5.6%) were offset by Latin America South (-12.7%) and Canada (-7.7%). Gross profit for the quarter dropped 1.8% to R$10.2 billion, and the margin contracted 30 basis points to 50.4%. Normalized profit dropped 0.6% to R$3.8 billion. Normalized EBITDA climbed 1.4% to R$6.5 billion, and the normalized EBITDA margin expanded by 80
Ambev (NYSE:ABEV) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.04 by 25 percent. This is unchanged from the same period last year. The company reported quarterly sales of $4.10 billion which beat the analyst consensus estimate of $3.85 billion by 6.39 percent. This is a 3.64 percent increase over sales of $3.95 billion the same period last year.
Capital market investors often look for entry points, hidden gems, and value bets. Quality stocks trading at or around their 52-week low levels offer one such opportunity window. We looked at established companies that, recently, made new 52-week lows. We point readers’ attention to three such stocks, with $35 billion market capitalizations. These are: Starbucks Corp (NASDAQ:SBUX), Gilead Sciences (NASDAQ:GILD) and Ambev SA (NYSE:ABEV). Starbucks Trading at around $86.83, the coffee franchise’s stock could potentially offer a buy-the-dip opportunity. The Seattle-based company’s shares command a market cap of over $98 billion on the stock market and sport an average three-month tradi
In today's rapidly evolving and fiercely competitive business landscape, it is crucial for investors and industry analysts to conduct comprehensive company evaluations. In this article, we will undertake an in-depth industry comparison, assessing Ambev (NYSE:ABEV) alongside its primary competitors in the Beverages industry. By meticulously examining crucial financial indicators, market positioning, and growth potential, we aim to provide valuable insights to investors and shed light on company's performance within the industry. Ambev Background Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and
The February labor market report presented mixed signals on the employment front, with a notable and larger-than-expected increase of 270,000 in nonfarm payrolls over the month, yet a higher-than-expected rise in the unemployment rate, moving from 3.7% to 3.9%. Additionally, the employment changes for December and January were revised downwards, subtracting a total of 167,000 nonfarm payrolls previously calculated for those two months. Perhaps the clearest data came from the trend in wages, which grew less than expected, thereby alleviating fears about their potential impact on inflation. In February, the pace of increase in average hourly earnings was 0.1%, a decrease from the 0.4%
Barclays analyst Benjamin Theurer downgrades Ambev (NYSE:ABEV) from Overweight to Equal-Weight and lowers the price target from $3.5 to $3.
The understudied threat of microplastics has become a major source of concern for large sectors of the population. While scientists have not yet identified the exact consequences of living around microscopic pieces of plastic, their presence has been found in everything from drinking water to human tissue to the air we breathe. According to a new study, an everyday solution could help get rid of as much as 90% of microplastics in tap water by simply boiling and filtering it. Microplastics: An Invisible Threat The term “microplastics” refers to small plastic fragments smaller than 5mm, found as contaminants in urban and natural environments. They come from multiple sources inc
6-K - AMBEV S.A. (0001565025) (Filer)
6-K - AMBEV S.A. (0001565025) (Filer)
6-K - AMBEV S.A. (0001565025) (Filer)
6-K - AMBEV S.A. (0001565025) (Filer)
6-K - AMBEV S.A. (0001565025) (Filer)
6-K - AMBEV S.A. (0001565025) (Filer)
6-K - AMBEV S.A. (0001565025) (Filer)
6-K - AMBEV S.A. (0001565025) (Filer)
6-K - AMBEV S.A. (0001565025) (Filer)
6-K - AMBEV S.A. (0001565025) (Filer)